Physician profile
Anthony Choi
NPI 1033505631
$2,422.47
in general payments reported to CMS, 2019-2025
9 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Transplant Hepatology provider received nationally (typical 2025 total: $508).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $525 · 2023: $580 · 2024: $1,195 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $914 · Consulting Fee: $800 · Travel and Lodging: $155 · Education: $27.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.37 |
| Consulting Fee | $800.00 |
| Travel and Lodging | $155.44 |
| Education | $27.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $800.00 | 2024 | |
| Abbott Laboratories | $469.38 | 2023-2024 | Aveir, Na |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $385.94 | 2022-2025 | Xifaxan |
| Gilead Sciences, INC. | $376.93 | 2022-2025 | Livdelzi |
| Abbvie INC. | $260.90 | 2022 | |
| Thrombolex, INC. | $58.31 | 2024 | Bashir Endovascular Catheter |
| Madrigal Pharmaceuticals | $32.21 | 2025 | Rezdiffra |
| Amgen INC. | $19.86 | 2023 | Amjevita, Avsola |
| Takeda Pharmaceuticals U.S.A., INC. | $18.94 | 2025 | Entyvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.